FDA Approves Genentech s Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Daewoong Pharmaceutical announced that the company aims for annual sales of its two new drugs, gastroesophageal reflux treatment Fexuclue and diabetes drug Envlo, to reach 1 trillion won ($736 million) by 2030. "Daewoong Pharmaceutical anticipates new launches and outlicensing deals involving Fexuclue and Envlo in the global pharmaceutical market," said Kim Do-young, head of Daewoong Pharmaceutical's G.
Prefilled Syringes Market to Hit $9 41 Billion, Globally, by 2030 at 5 6% CAGR: Exclusive Report by Coherent Market Insights (CMI) einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Sun Chemical Releases Spring 2023 Regulatory Newsletter textileworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from textileworld.com Daily Mail and Mail on Sunday newspapers.